Comment: Patent Box consultation will provide greater certainty to UK businesses, says Withers & Rogers

26 October 2015

Reassurance on the future of the UK’s Patent Box Scheme is positive news for UK companies, according to leading intellectual property firm, Withers & Rogers.

A government consultation on the Patent Box Scheme which opened on October 22, will run until December 4, 2015. The government will essentially ensure the UK’s tax regimes comply with the Organization for Economic Cooperation and Development’s (OECD) recommendations.

Michael Jaeger, patent attorney at Withers & Rogers, said, “The launch of the consultation is welcome news and it will allow innovative UK companies to plan for their future with more certainty. The government has now made its position on the Patent Box Scheme clear, which is very important for UK businesses and innovation. This should remove any doubt for companies who undertake their R&D activity in the UK, allowing them to receive the same level of tax relief on patented technologies.”

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK